Drug recall · May 8, 2019
Revonto recall
Why: Presence of Precipitate: Appearance is Out of Specification for the reconstituted solution during 24-month stability time point analysis.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Revonto (dantrolene sodium for injection), 20 mg/vial, For treatment of malignant hyperthermia, For Intravenous Use Only, Rx Only, Made in Italy, Dist. by: US WorldMeds, LLC, Louisville, KY 40241, NDC: 27505-003-67
- Lots / codes
Lot: 17REV01, Exp. 12/2019
- Quantity
- 6456 vials
- Company
- US Worldmeds LLC, Louisville, KY
- Distribution
- Nationwide in the USA
- Initiated
- April 25, 2019 · Voluntary: Firm initiated
- Classified
- May 10, 2019
- Reported
- May 8, 2019
- Ended
- September 17, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dantrolene
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.